Involvement of Proteasome and Macrophages M2 in the Protection Afforded by Telmisartan against the Acute Myocardial Infarction in Zucker Diabetic Fatty Rats with Metabolic Syndrome
This study investigated the involvement of proteasome and macrophages M2 in the protection afforded by telmisartan against the acute myocardial infarction in Zucker diabetic fatty (ZDF) rats with metabolic syndrome. ZDF rats were treated for three weeks with telmisartan at doses of 7 and 12 mg/kg/da...
Saved in:
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2014/972761 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832564877822001152 |
---|---|
author | C. Di Filippo C. Rossi B. Ferraro R. Maisto A. De Angelis F. Ferraraccio A. Rotondo M. D’Amico |
author_facet | C. Di Filippo C. Rossi B. Ferraro R. Maisto A. De Angelis F. Ferraraccio A. Rotondo M. D’Amico |
author_sort | C. Di Filippo |
collection | DOAJ |
description | This study investigated the involvement of proteasome and macrophages M2 in the protection afforded by telmisartan against the acute myocardial infarction in Zucker diabetic fatty (ZDF) rats with metabolic syndrome. ZDF rats were treated for three weeks with telmisartan at doses of 7 and 12 mg/kg/day. After treatment, rats were subjected to a 25 min occlusion of the left descending coronary artery followed by 2 h reperfusion (I/R). At the end of the I/R period, biochemical, immunohistochemical, and echocardiographic evaluations were done. Telmisartan treatment (7 mg/kg and 12 mg/kg) reduced the myocardial infarct size, the expression of proteasome subunits 20S and 26S, and the protein ubiquitin within the heart. The compound has led to an increased M2 macrophage phenotype within the cardiac specimens and a modification of the cardiac cytokine and chemokine profile. This was functionally translated in improved cardiac performance as evidenced by echography after 2 h reperfusion. 7 mg/kg/day telmisartan was sufficient to improve the left ventricular ejection fraction LVEF of the rat heart recorded after I/R (e.g., vehicle 38 ± 2.2%; telmisartan 54 ± 2.7%) and was sufficient to improve the diastolic function and the myocardial performance index up to values of 0.6 ± 0.01 measured after I/R. |
format | Article |
id | doaj-art-39c4a055c0624b979abd0ac6ed5f93a7 |
institution | Kabale University |
issn | 0962-9351 1466-1861 |
language | English |
publishDate | 2014-01-01 |
publisher | Wiley |
record_format | Article |
series | Mediators of Inflammation |
spelling | doaj-art-39c4a055c0624b979abd0ac6ed5f93a72025-02-03T01:10:01ZengWileyMediators of Inflammation0962-93511466-18612014-01-01201410.1155/2014/972761972761Involvement of Proteasome and Macrophages M2 in the Protection Afforded by Telmisartan against the Acute Myocardial Infarction in Zucker Diabetic Fatty Rats with Metabolic SyndromeC. Di Filippo0C. Rossi1B. Ferraro2R. Maisto3A. De Angelis4F. Ferraraccio5A. Rotondo6M. D’Amico7Department of Experimental Medicine, Section of Pharmacology “L. Donatelli”, Second University of Naples, 80138 Naples, ItalyRadiology, Radiotherapy and Nuclear Medicine Unit, Second University of Naples, 80138 Naples, ItalyDepartment of Experimental Medicine, Section of Pharmacology “L. Donatelli”, Second University of Naples, 80138 Naples, ItalyDepartment of Experimental Medicine, Section of Pharmacology “L. Donatelli”, Second University of Naples, 80138 Naples, ItalyDepartment of Experimental Medicine, Section of Pharmacology “L. Donatelli”, Second University of Naples, 80138 Naples, ItalyDepartment of Clinical, Public and Preventive Medicine, Second University of Naples, 80138 Naples, ItalyRadiology, Radiotherapy and Nuclear Medicine Unit, Second University of Naples, 80138 Naples, ItalyDepartment of Experimental Medicine, Section of Pharmacology “L. Donatelli”, Second University of Naples, 80138 Naples, ItalyThis study investigated the involvement of proteasome and macrophages M2 in the protection afforded by telmisartan against the acute myocardial infarction in Zucker diabetic fatty (ZDF) rats with metabolic syndrome. ZDF rats were treated for three weeks with telmisartan at doses of 7 and 12 mg/kg/day. After treatment, rats were subjected to a 25 min occlusion of the left descending coronary artery followed by 2 h reperfusion (I/R). At the end of the I/R period, biochemical, immunohistochemical, and echocardiographic evaluations were done. Telmisartan treatment (7 mg/kg and 12 mg/kg) reduced the myocardial infarct size, the expression of proteasome subunits 20S and 26S, and the protein ubiquitin within the heart. The compound has led to an increased M2 macrophage phenotype within the cardiac specimens and a modification of the cardiac cytokine and chemokine profile. This was functionally translated in improved cardiac performance as evidenced by echography after 2 h reperfusion. 7 mg/kg/day telmisartan was sufficient to improve the left ventricular ejection fraction LVEF of the rat heart recorded after I/R (e.g., vehicle 38 ± 2.2%; telmisartan 54 ± 2.7%) and was sufficient to improve the diastolic function and the myocardial performance index up to values of 0.6 ± 0.01 measured after I/R.http://dx.doi.org/10.1155/2014/972761 |
spellingShingle | C. Di Filippo C. Rossi B. Ferraro R. Maisto A. De Angelis F. Ferraraccio A. Rotondo M. D’Amico Involvement of Proteasome and Macrophages M2 in the Protection Afforded by Telmisartan against the Acute Myocardial Infarction in Zucker Diabetic Fatty Rats with Metabolic Syndrome Mediators of Inflammation |
title | Involvement of Proteasome and Macrophages M2 in the Protection Afforded by Telmisartan against the Acute Myocardial Infarction in Zucker Diabetic Fatty Rats with Metabolic Syndrome |
title_full | Involvement of Proteasome and Macrophages M2 in the Protection Afforded by Telmisartan against the Acute Myocardial Infarction in Zucker Diabetic Fatty Rats with Metabolic Syndrome |
title_fullStr | Involvement of Proteasome and Macrophages M2 in the Protection Afforded by Telmisartan against the Acute Myocardial Infarction in Zucker Diabetic Fatty Rats with Metabolic Syndrome |
title_full_unstemmed | Involvement of Proteasome and Macrophages M2 in the Protection Afforded by Telmisartan against the Acute Myocardial Infarction in Zucker Diabetic Fatty Rats with Metabolic Syndrome |
title_short | Involvement of Proteasome and Macrophages M2 in the Protection Afforded by Telmisartan against the Acute Myocardial Infarction in Zucker Diabetic Fatty Rats with Metabolic Syndrome |
title_sort | involvement of proteasome and macrophages m2 in the protection afforded by telmisartan against the acute myocardial infarction in zucker diabetic fatty rats with metabolic syndrome |
url | http://dx.doi.org/10.1155/2014/972761 |
work_keys_str_mv | AT cdifilippo involvementofproteasomeandmacrophagesm2intheprotectionaffordedbytelmisartanagainsttheacutemyocardialinfarctioninzuckerdiabeticfattyratswithmetabolicsyndrome AT crossi involvementofproteasomeandmacrophagesm2intheprotectionaffordedbytelmisartanagainsttheacutemyocardialinfarctioninzuckerdiabeticfattyratswithmetabolicsyndrome AT bferraro involvementofproteasomeandmacrophagesm2intheprotectionaffordedbytelmisartanagainsttheacutemyocardialinfarctioninzuckerdiabeticfattyratswithmetabolicsyndrome AT rmaisto involvementofproteasomeandmacrophagesm2intheprotectionaffordedbytelmisartanagainsttheacutemyocardialinfarctioninzuckerdiabeticfattyratswithmetabolicsyndrome AT adeangelis involvementofproteasomeandmacrophagesm2intheprotectionaffordedbytelmisartanagainsttheacutemyocardialinfarctioninzuckerdiabeticfattyratswithmetabolicsyndrome AT fferraraccio involvementofproteasomeandmacrophagesm2intheprotectionaffordedbytelmisartanagainsttheacutemyocardialinfarctioninzuckerdiabeticfattyratswithmetabolicsyndrome AT arotondo involvementofproteasomeandmacrophagesm2intheprotectionaffordedbytelmisartanagainsttheacutemyocardialinfarctioninzuckerdiabeticfattyratswithmetabolicsyndrome AT mdamico involvementofproteasomeandmacrophagesm2intheprotectionaffordedbytelmisartanagainsttheacutemyocardialinfarctioninzuckerdiabeticfattyratswithmetabolicsyndrome |